Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannesson

Showing results (31-40 of 1,062) with videos related to

Pageof 107
Sort By:
European Heart Journal|June 29, 2001
At what coronary risk level is it cost-effective to initiate cholesterol lowering drug treatment in primary prevention?M Johannesson
Pharmacoeconomics|February 7, 1995
The cost effectiveness of hypertension treatment in SwedenM Johannesson
Pharmacoeconomics|April 7, 1997
Avoiding double-counting in pharmacoeconomic studiesM Johannesson
Journal of Human Hypertension|February 1, 1996
The cost-effectiveness of hypertension treatment in Sweden: an analysis of the criteria for intervention and the choice of drug treatmentM Johannesson
Lakartidningen|November 23, 1994
[Exercise is effective in back pain]M Johannesson
Acta Dermato-Venereologica. Supplementum|January 1, 1982
The initial psoriatic lesion. An experimental investigation with cell kinetic morphometric and immunological techniquesA Johannesson
International Journal of Technology Assessment in Health Care|January 1, 1992
Economic evaluation of hypertension treatmentM Johannesson
Health Policy (Amsterdam, Netherlands)|December 10, 1991
Economic evaluation of lipid lowering--a feasibility test of the contingent valuation approachM Johannesson
Journal of Health Economics|October 28, 1999
On aggregating QALYs: a comment on DolanM Johannesson
The Journal of Dermatologic Surgery and Oncology|June 1, 1988
Razor blade surgery of large vessels on the noseA Johannesson
Pageof 107

Showing results (31-40 of 1,062) with videos related to

Sort By:
Pageof 107
European Heart Journal|June 29, 2001
At what coronary risk level is it cost-effective to initiate cholesterol lowering drug treatment in primary prevention?M Johannesson
Pharmacoeconomics|February 7, 1995
The cost effectiveness of hypertension treatment in SwedenM Johannesson
Pharmacoeconomics|April 7, 1997
Avoiding double-counting in pharmacoeconomic studiesM Johannesson
Journal of Human Hypertension|February 1, 1996
The cost-effectiveness of hypertension treatment in Sweden: an analysis of the criteria for intervention and the choice of drug treatmentM Johannesson
Lakartidningen|November 23, 1994
[Exercise is effective in back pain]M Johannesson
Acta Dermato-Venereologica. Supplementum|January 1, 1982
The initial psoriatic lesion. An experimental investigation with cell kinetic morphometric and immunological techniquesA Johannesson
International Journal of Technology Assessment in Health Care|January 1, 1992
Economic evaluation of hypertension treatmentM Johannesson
Health Policy (Amsterdam, Netherlands)|December 10, 1991
Economic evaluation of lipid lowering--a feasibility test of the contingent valuation approachM Johannesson
Journal of Health Economics|October 28, 1999
On aggregating QALYs: a comment on DolanM Johannesson
The Journal of Dermatologic Surgery and Oncology|June 1, 1988
Razor blade surgery of large vessels on the noseA Johannesson
Pageof 107